Cordlife Group Ltd
SGX:P8A

Watchlist Manager
Cordlife Group Ltd Logo
Cordlife Group Ltd
SGX:P8A
Watchlist
Price: 0.155 SGD -1.9% Market Closed
Market Cap: 39.7m SGD
Have any thoughts about
Cordlife Group Ltd?
Write Note

Cordlife Group Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cordlife Group Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Cordlife Group Ltd
SGX:P8A
Note Receivable
S$62.3m
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Q & M Dental Group (Singapore) Ltd
SGX:QC7
Note Receivable
S$2.4m
CAGR 3-Years
N/A
CAGR 5-Years
17%
CAGR 10-Years
23%
Healthway Medical Corporation Ltd
SGX:5NG
Note Receivable
S$36k
CAGR 3-Years
-75%
CAGR 5-Years
-55%
CAGR 10-Years
-52%
T
Talkmed Group Ltd
SGX:5G3
Note Receivable
S$198k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
HC Surgical Specialists Ltd
SGX:1B1
Note Receivable
S$80k
CAGR 3-Years
N/A
CAGR 5-Years
-32%
CAGR 10-Years
N/A
EUDA Health Holdings Ltd
NASDAQ:EUDA
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Cordlife Group Ltd
Glance View

Market Cap
39.7m SGD
Industry
Health Care

Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The Company’s segments include Banking and Diagnostic. The Banking segment comprises the banking of samples, such as cord blood, cord lining and cord tissue. The Diagnostic segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The firm offers a range of diagnostics services for the family, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.

P8A Intrinsic Value
0.263 SGD
Undervaluation 41%
Intrinsic Value
Price

See Also

What is Cordlife Group Ltd's Note Receivable?
Note Receivable
62.3m SGD

Based on the financial report for Jun 30, 2024, Cordlife Group Ltd's Note Receivable amounts to 62.3m SGD.

What is Cordlife Group Ltd's Note Receivable growth rate?
Note Receivable CAGR 10Y
3%

Over the last year, the Note Receivable growth was -2%. The average annual Note Receivable growth rates for Cordlife Group Ltd have been -3% over the past three years , -2% over the past five years , and 3% over the past ten years .

Back to Top